Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel PK/PD Optimization in Solid Tumors
NCT00703378Phase 2Completed
- Sponsor
- National University Hospital
- Start
- May 2006
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of docetaxel in solid tumor (3 arms), sponsored by National University Hospital. Primary endpoints: Change in Neutrophil Counts at 3 weeks and Area Under the Curve for Docetaxel at 3 weeks. Started May 2006; status: completed.
02
Drugs
docetaxel
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT00703378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00703378.